Follow us on

Providing direction for successful oncology drug development

Clinical trials are all about obtaining valuable data to show proof of concept, protecting patients and compiling the regulatory dossier, but developing anticancer drugs is a complex business. The right expertise is required to navigate the best way forward. Imagine availing of in-depth knowhow and receiving proactive guidance from oncology trial design to full execution. This will not only give you a head start, but will also allow you to be on top of your data, make informed decisions, mitigate risks and identify opportunities during study conduct.

SMS-oncology sets itself apart from typical CROs by providing Direction during the entire Drug-Data-Dossier path (our unique “4D” service). With our team of oncology professionals, we support you with topnotch clinical operations and expert advice through meaningful insights, which gives your oncology compound the highest chance of success.

Our advantages

  • Proactively addressing challenges before they turn into hurdles
  • Strategic clinical development advice that can be directly translated into clinical operations
  • Turning complex data into meaningful insights during study conduct using our oncology expertise
Oncology Experts
  • In-depth knowledge of the complex nature of early phase oncology and immuno-oncology studies
  • Dedicated professionals with oncology know-how and experience in all functions of the company
  • Extensive network of Key Opinion Leaders throughout Europe
Responsiveness, Quality & Flexibility
  • Responsive and "right-sized" project teams for close collaboration, flexibility and fast-decision making
  • Close and personal involvement of the management team ensuring a high standard of quality
  • Delivering tailor made solutions by offering full or functional services as needed


  • AAA
  • BiOrion
  • BliNK Biomedical SAS
  • Cantargia
  • Complix
  • COR2ED
  • Cristal Therapeutics
  • Delcath Systems
  • eTheRNA
  • Glycostem
  • logo hartwig
  • HYD Pharma
  • Immutep
  • iOnctura
  • ISA Pharmaceuticals
  • LinXis Pharmaceuticals
  • lipo
  • Merus
  • Novalon
  • Pfizer Oncology
  • Teva Nederland
  • Transimmune
  • UCL Technology Fund
  • logo_xenikos
  • 2-BBB Medicines


SMS-oncology moves to new office

21 August 2017

Cantargia and SMS-oncology conclude agreement on implementation of clinical phase I/IIa trial

16 December 2016

SMS-oncology launches new service "Expert protocol advice (free)"

9 September 2016


BIO-Europe Spring 2018

Amsterdam, The Netherlands (12-14 March 2018)

2018 ACDM Annual Conference

Brussels, Belgium (13 March 2018)

Blog & Newsletter

Oncology Highlights - January 2018

5 Februari 2018

EMA anticancer drug recommendations for approval in 2017

23 Januari 2018

Oncology Highlights - December 2017

3 Januari 2018
Contact us for more information Request for proposal